| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |






*
Division of Nephrology, McMaster University, Hamilton, Canada
Centre for Gene Therapeutics, McMaster University, Hamilton,
Canada
Renal Division Scientific Affairs, Baxter Healthcare Corp., McGaw Park,
Illinois.
Correspondence to Dr. Jack Gauldie, Department of Pathology and Molecular Medicine, McMaster University, 1200 Main Street W., Room 2N16, Hamilton, Ontario, Canada L8N 3Z5. Phone: 905-521-2100, ext. 76332; Fax: 905-577-0198; E-mail: gauldie{at}mcmaster.ca
Abstract. Long-term peritoneal dialysis is limited by physiologic changes in the peritoneum that lead to ultrafiltration failure. To determine the role of profibrotic cytokines in the alteration of peritoneal transport, a rodent model of transforming growth factor-ß (TGF-ß)-mediated peritoneal fibrosis was established. An adenoviral vector driving the active form of TGF-ß1 (AdTGFß1) was administered intraperitoneally, and peritoneal structure and function were evaluated for 28 d after infection. Seven days after AdTGFß1 infection, thickening of the peritoneum, with cellular proliferation and increased vascularization, was noted. By day 28, there was persistent thickening and extensive collagen deposition. The mesenteric collagen content was significantly elevated, compared with control adenovirus-treated animals, 21 d after infection (2.9 versus 1.8 mg hydroxyproline/g tissue, P = 0.006). Blood vessel density, as measured using factor VIII immunohistochemical analyses, was significantly increased from day 4 to day 21 but decreased by day 28. Animals infected with AdTGFß1 demonstrated increased transport of solutes and decreased net ultrafiltration, which was maximal on day 7 and returned to baseline levels by day 28. It was demonstrated in vitro and in vivo that TGF-ß1 induced production of vascular endothelial growth factor. Overexpression of TGF-ß1 after adenovirus-mediated gene transfer causes peritoneal fibrosis, neoangiogenesis, and increased peritoneal membrane solute transport. This model should allow further delineation of the relative contributions of profibrotic and angiogenic cytokines to changes in peritoneal function and may lead to potential new interventions for peritoneal membrane failure.
This article has been cited by other articles:
![]() |
I. Kolesnyk, M. Noordzij, F. W. Dekker, E. W. Boeschoten, and R. T. Krediet A positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients Nephrol. Dial. Transplant., January 1, 2009; 24(1): 272 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Cina, P. Patel, J. C. Bethune, J. Thoma, J. C. Rodriguez-Lecompte, C. M. Hoff, L. Liu, and P. J. Margetts Peritoneal morphological and functional changes associated with platelet-derived growth factor B Nephrol. Dial. Transplant., September 4, 2008; (2008) gfn498v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nishimura, Y. Ito, M. Mizuno, A. Tanaka, Y. Morita, S. Maruyama, Y. Yuzawa, and S. Matsuo Mineralocorticoid receptor blockade ameliorates peritoneal fibrosis in new rat peritonitis model Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1084 - F1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Decologne, M. Kolb, P. J. Margetts, F. Menetrier, Y. Artur, C. Garrido, J. Gauldie, P. Camus, and P. Bonniaud TGF-beta1 Induces Progressive Pleural Scarring and Subpleural Fibrosis J. Immunol., November 1, 2007; 179(9): 6043 - 6051. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ro, C. Hamada, M. Inaba, H. Io, K. Kaneko, and Y. Tomino Inhibitory effects of matrix metalloproteinase inhibitor ONO-4817 on morphological alterations in chlorhexidine gluconate-induced peritoneal sclerosis rats Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2838 - 2848. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Guo, J. C.K. Leung, M. F. Lam, L. Y.Y. Chan, A. W.L. Tsang, H. Y. Lan, and K. N. Lai Smad7 Transgene Attenuates Peritoneal Fibrosis in Uremic Rats Treated with Peritoneal Dialysis J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2689 - 2703. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Aroeira, A. Aguilera, J. A. Sanchez-Tomero, M. A. Bajo, G. del Peso, J. A. Jimenez-Heffernan, R. Selgas, and M. Lopez-Cabrera Epithelial to Mesenchymal Transition and Peritoneal Membrane Failure in Peritoneal Dialysis Patients: Pathologic Significance and Potential Therapeutic Interventions J. Am. Soc. Nephrol., July 1, 2007; 18(7): 2004 - 2013. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Fang, C.-J. Yen, Y.-M. Chen, T.-S. Chu, M.-T. Lin, J.-Y. Yang, and T.-J. Tsai Diltiazem suppresses collagen synthesis and IL-1{beta}-induced TGF-{beta}1 production on human peritoneal mesothelial cells Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1340 - 1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Vallance, M. I. Gunawan, B. Hewlett, P. Bercik, C. Van Kampen, F. Galeazzi, P. J. Sime, J. Gauldie, and S. M. Collins TGF-{beta}1 gene transfer to the mouse colon leads to intestinal fibrosis Am J Physiol Gastrointest Liver Physiol, July 1, 2005; 289(1): G116 - G128. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Flessner The transport barrier in intraperitoneal therapy Am J Physiol Renal Physiol, March 1, 2005; 288(3): F433 - F442. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Margetts, P. Bonniaud, L. Liu, C. M. Hoff, C. J. Holmes, J. A. West-Mays, and M. M. Kelly Transient Overexpression of TGF-{beta}1 Induces Epithelial Mesenchymal Transition in the Rodent Peritoneum J. Am. Soc. Nephrol., February 1, 2005; 16(2): 425 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Motomura, H. Kanbayashi, W. I. Khan, Y. Deng, P. A. Blennerhassett, P. J. Margetts, J. Gauldie, K. Egashira, and S. M. Collins The gene transfer of soluble VEGF type I receptor (Flt-1) attenuates peritoneal fibrosis formation in mice but not soluble TGF-{beta} type II receptor gene transfer Am J Physiol Gastrointest Liver Physiol, January 1, 2005; 288(1): G143 - G150. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nakamura and T. Niwa Pyridoxal Phosphate and Hepatocyte Growth Factor Prevent Dialysate-Induced Peritoneal Damage J. Am. Soc. Nephrol., January 1, 2005; 16(1): 144 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Martin-Martinez, M. Stoenoiu, C. Verkaeren, O. Devuyst, and C. Delporte Recombinant adenovirus administration in rat peritoneum: endothelial expression and safety concerns Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1293 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yanez-Mo, E. Lara-Pezzi, R. Selgas, M. Ramirez-Huesca, C. Dominguez-Jimenez, J. A. Jimenez-Heffernan, A. Aguilera, J. A. Sanchez-Tomero, M. A. Bajo, V. Alvarez, et al. Peritoneal Dialysis and Epithelial-to-Mesenchymal Transition of Mesothelial Cells N. Engl. J. Med., January 30, 2003; 348(5): 403 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Margetts, M. Kolb, L. Yu, C. M. Hoff, C. J. Holmes, D. C. Anthony, and J. Gauldie Inflammatory Cytokines, Angiogenesis, and Fibrosis in the Rat Peritoneum Am. J. Pathol., June 1, 2002; 160(6): 2285 - 2294. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Margetts, S. Gyorffy, M. Kolb, L. Yu, C. M. Hoff, C. J. Holmes, and J. Gauldie Antiangiogenic and Antifibrotic Gene Therapy in a Chronic Infusion Model of Peritoneal Dialysis in Rats J. Am. Soc. Nephrol., March 1, 2002; 13(3): 721 - 728. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673